The impact of COVID-19 infection, the pandemic and its associated control measures on patients with Pompe disease.
Theunissen MTM, van den Elsen RM, House TL, Crittenden B, van Doorn PA, van der Ploeg AT, Kruijshaar ME, van der Beek NAME
Journal of neurology, 2023 Nov 20
Abstract
Patients with Pompe disease, a rare metabolic myopathy, were thought to be at increased risk of severe COVID-19 disease during the pandemic. In addition, the lockdown may have affected their regular treatment.